NeoTract’s UroLift system gains expanded insurance coverage

This article was originally published here

Teleflex (NYSE:TFX) subsidiary NeoTract said that two more health insurers have agreed to offer coverage for the company’s UroLift system or patients with an enlarged prostate.

The Wayne, Penn.-based subsidiary of Teleflex said that major U.S. insurer Humana and the Motion Picture Industry Pension & Health Plans (MPI), administered by Anthem Blue Cross, have added UroLift to its covered treatment systems. UroLift is a minimally invasive in-office treatment designed to provide rapid relief and recovery from the symptoms of benign prostatic hyperplasia (BPH).

“These coverage decisions are a major testament to the clinical benefits of the UroLift System for treating Benign Prostatic Hyperplasia (BPH), a common condition that significantly impacts the overall health of men with symptomatic BPH as well as the quality of life for those men and their partners,” said Teleflex interventional urology unit president Dave Amerson in a prepared statement. “We are pleased to see the continued acceptance of the UroLift System as a standard-of-care therapy for patients with symptomatic BPH. This coverage milestone will expand lasting and durable symptom relief to millions of men, allowing them to return to a healthier and better quality of life.”

With these recent coverage decisions, a large majority of insured men in America now have access to the UroLift System procedure using their health insurance benefits, NeoTract said.

 

 

The post NeoTract’s UroLift system gains expanded insurance coverage appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply